JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $85 | $171 | $172 | $270 |
| - Cash | $13 | $19 | $13 | $31 |
| + Debt | $38 | $23 | $23 | $18 |
| Enterprise Value | $110 | $176 | $181 | $258 |
| Revenue | $33 | $43 | $34 | $51 |
| % Growth | -22.9% | 24.8% | -32.8% | – |
| Gross Profit | $22 | $31 | $25 | $41 |
| % Margin | 65.7% | 72.9% | 74.1% | 79.5% |
| EBITDA | -$3 | $11 | $7 | $21 |
| % Margin | -8.7% | 24.6% | 21.7% | 41.9% |
| Net Income | -$5 | $6 | $4 | $15 |
| % Margin | -14.4% | 12.8% | 11% | 28.4% |
| EPS Diluted | -38.43 | 43.92 | 30.22 | 116.79 |
| % Growth | -187.5% | 45.3% | -74.1% | – |
| Operating Cash Flow | -$5 | $9 | -$6 | $9 |
| Capital Expenditures | -$10 | -$2 | -$9 | -$11 |
| Free Cash Flow | -$15 | $7 | -$14 | -$2 |